APFP
HAE icon

Action Point Financial Planning’s Haemonetics HAE Stock Holding History

Action Point Financial Planning’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Buy
+19
New +$1.22K ﹤0.01% 2404

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Action Point Financial Planning's HAE Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Haemonetics (HAE) in Q2 2026: 19 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #2404 among its holdings.

327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Action Point Financial Planning held 19 shares of Haemonetics worth $1.27K as of Q2 2026.
  • Haemonetics was a new Action Point Financial Planning position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #2404 holding.
  • 327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.